Scholarlink

<p>Aluminum exposure is linked to the development of many neurodegenerative disorders including Alzheimer’s disease (AD), by disrupting molecular and cellular homeostasis in the brain. <i>Chlorella vulgaris</i> (CV), a green microalga, is reported to have antioxidant, anti-inflammatory, and neuroprotective properties. However, their role on Aluminum chloride (AlCl<sub>3</sub>)-induced AD and amyloid β (Aβ) clearance has not yet been fully elucidated. This research aimed to investigate the protective effectiveness of CV-loaded niosome (CV-LN) as a drug delivery system, in comparison to free form, against AlCl3-induced Alzheimer’s-like neurodegeneration in rats with special emphasis on SIRT1/miRNA-134/GSK3β axis. A niosomal formulation of Span 60, and cholesterol was chosen as an optimum formulation. Administration of CV or CV-LN dramatically improves the impaired oxidative markers, behavioral deficits, cholinergic and serotonergic dysfunctions, by significantly inhibiting monoamine oxidase, acetylcholinesterase activities and increasing serotonin level in brain of AlCl<sub>3</sub>-exposed rats. In parallel, CV or CV-LN triggers the activation of Sirtuin-1 (SIRT1) which downregulates miRNA-134, leading to increased brain-derived neurotrophic factor (BDNF) expression and improved neuronal survival and synaptic plasticity. Furthermore, CV or CV-LN decreases glycogen synthase kinase 3 beta (GSK3β)-mediated Tau hyperphosphorylation associated with clearance of Aβ. Additionally, CV or CV-LN significantly inhibits neuroinflammation by decreasing glial fibrillary acidic protein (GFAP), and apoptosis via modulating BAX, Caspase-3 and BCL2. Histopathological evaluations also supported the above findings. CV-LN formulations exhibited greater neuroprotective efficacy in a rat model, possibly due to better brain delivery and bioavailability. Eventually, CV and particularly CV-LN may hold promise as potential therapeutic candidates for further investigation in the context of neurodegenerative disorders and AD, possibly through modulation of SIRT1/miRNA-134/GSK3β axis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Neuroprotective effects of Chlorella vulgaris loaded niosomes via SIRT1 activation in aluminum chloride-induced Alzheimer’s model

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月18日

查看全文
  • Rania A. Radi,
  • Mohamed A. Kandeil,
  • Eman T. Mohammed,
  • Marwa A. Ibrahim,
  • Amr Gamal,
  • Abdel-Razik H. Abdel-Razik,
  • Fatma Khalil,
  • Dina Sabry

摘要

Aluminum exposure is linked to the development of many neurodegenerative disorders including Alzheimer’s disease (AD), by disrupting molecular and cellular homeostasis in the brain. Chlorella vulgaris (CV), a green microalga, is reported to have antioxidant, anti-inflammatory, and neuroprotective properties. However, their role on Aluminum chloride (AlCl3)-induced AD and amyloid β (Aβ) clearance has not yet been fully elucidated. This research aimed to investigate the protective effectiveness of CV-loaded niosome (CV-LN) as a drug delivery system, in comparison to free form, against AlCl3-induced Alzheimer’s-like neurodegeneration in rats with special emphasis on SIRT1/miRNA-134/GSK3β axis. A niosomal formulation of Span 60, and cholesterol was chosen as an optimum formulation. Administration of CV or CV-LN dramatically improves the impaired oxidative markers, behavioral deficits, cholinergic and serotonergic dysfunctions, by significantly inhibiting monoamine oxidase, acetylcholinesterase activities and increasing serotonin level in brain of AlCl3-exposed rats. In parallel, CV or CV-LN triggers the activation of Sirtuin-1 (SIRT1) which downregulates miRNA-134, leading to increased brain-derived neurotrophic factor (BDNF) expression and improved neuronal survival and synaptic plasticity. Furthermore, CV or CV-LN decreases glycogen synthase kinase 3 beta (GSK3β)-mediated Tau hyperphosphorylation associated with clearance of Aβ. Additionally, CV or CV-LN significantly inhibits neuroinflammation by decreasing glial fibrillary acidic protein (GFAP), and apoptosis via modulating BAX, Caspase-3 and BCL2. Histopathological evaluations also supported the above findings. CV-LN formulations exhibited greater neuroprotective efficacy in a rat model, possibly due to better brain delivery and bioavailability. Eventually, CV and particularly CV-LN may hold promise as potential therapeutic candidates for further investigation in the context of neurodegenerative disorders and AD, possibly through modulation of SIRT1/miRNA-134/GSK3β axis.